BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33914323)

  • 21. Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroids.
    Tonguc T; Recker F; Ganslmeier J; Strunk HM; Pieper CC; Ramig O; Welz S; Egger EK; Mutschler N; Warwas L; Essler M; Mustea A; Conrad R; Marinova M
    Sci Rep; 2022 Dec; 12(1):21155. PubMed ID: 36476975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: a preliminary experience.
    Cheung VYT; Lam TPW; Jenkins CR; Lam SW; Cheung GKI; Chan SSY; Choi WK
    J Obstet Gynaecol; 2019 Aug; 39(6):833-839. PubMed ID: 31006301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes.
    Kim YS; Kim JH; Rhim H; Lim HK; Keserci B; Bae DS; Kim BG; Lee JW; Kim TJ; Choi CH
    Radiology; 2012 May; 263(2):600-9. PubMed ID: 22403170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results.
    Froeling V; Meckelburg K; Schreiter NF; Scheurig-Muenkler C; Kamp J; Maurer MH; Beck A; Hamm B; Kroencke TJ
    Eur J Radiol; 2013 Dec; 82(12):2265-9. PubMed ID: 24075785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Focused Ultrasound Myoma Outcome Study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy.
    Verpalen IM; de Boer JP; Linstra M; Pol RLI; Nijholt IM; Moonen CTW; Bartels LW; Franx A; Boomsma MF; Braat MNG
    Eur Radiol; 2020 May; 30(5):2473-2482. PubMed ID: 32040725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR-guided HIFU treatment of symptomatic uterine fibroids using novel feedback-regulated volumetric ablation: effectiveness and clinical practice.
    Ruhnke H; Eckey T; Bohlmann MK; Beldoch MP; Neumann A; Agic A; Hägele J; Diedrich K; Barkhausen J; Hunold P
    Rofo; 2013 Oct; 185(10):983-91. PubMed ID: 24490234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased MR-guided high intensity focused ultrasound (MR-HIFU) sonication efficiency of uterine fibroids after carbetocin administration.
    Anneveldt KJ; van 't Oever HJ; Verpalen IM; Nijholt IM; Bartels W; Dijkstra JR; van den Hoed RD; van 't Veer-Ten Kate M; de Boer E; Veersema S; Huirne JAF; Schutte JM; Boomsma MF
    Eur J Radiol Open; 2022; 9():100413. PubMed ID: 35340827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy.
    Voogt MJ; Trillaud H; Kim YS; Mali WP; Barkhausen J; Bartels LW; Deckers R; Frulio N; Rhim H; Lim HK; Eckey T; Nieminen HJ; Mougenot C; Keserci B; Soini J; Vaara T; Köhler MO; Sokka S; van den Bosch MA
    Eur Radiol; 2012 Feb; 22(2):411-7. PubMed ID: 21901565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates.
    Ikink ME; Nijenhuis RJ; Verkooijen HM; Voogt MJ; Reuwer PJ; Smeets AJ; Lohle PN; van den Bosch MA
    Eur Radiol; 2014 Oct; 24(10):2649-57. PubMed ID: 25117743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midterm results after uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for symptomatic uterine fibroids.
    Froeling V; Meckelburg K; Scheurig-Muenkler C; Schreiter NF; Kamp J; Maurer MH; Beck A; Hamm B; Kroencke TJ
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1508-1513. PubMed ID: 23456309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence and Risk Factors for Perioperative Treatment Discontinuation during Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MR-HIFU) Therapy in Symptomatic Uterine Fibroids-A Retrospective Case-Control Study.
    Kociuba J; Łoziński T; Latra K; Korczyńska L; Skowyra A; Zarychta E; Ciebiera M
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early evaluation of magnetic resonance imaging guided focused ultrasound sonication in the treatment of uterine fibroids.
    Himabindu Y; Sriharibabu M; Nyapathy V; Mishra A
    Indian J Med Res; 2014 Feb; 139(2):267-72. PubMed ID: 24718402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine fibroids: postsonication temperature decay rate enables prediction of therapeutic responses to MR imaging-guided high-intensity focused ultrasound ablation.
    Kim YS; Park MJ; Keserci B; Nurmilaukas K; Köhler MO; Rhim H; Lim HK
    Radiology; 2014 Feb; 270(2):589-600. PubMed ID: 24072779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of (Cost-)Effectiveness of Magnetic Resonance Image-Guided High-Intensity-Focused Ultrasound With Standard (Minimally) Invasive Fibroid Treatments: Protocol for a Multicenter Randomized Controlled Trial (MYCHOICE).
    Anneveldt KJ; Nijholt IM; Schutte JM; Dijkstra JR; Frederix GWJ; Ista E; Verpalen IM; Veersema S; Huirne JAF; Hehenkamp WJK; Boomsma MF
    JMIR Res Protoc; 2021 Nov; 10(11):e29467. PubMed ID: 34821569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Technical Aspects of MR-Guided High Intensity Focused Ultrasound for Treatment of Symptomatic Uterine Fibroids.
    Rueff LE; Raman SS
    Semin Intervent Radiol; 2013 Dec; 30(4):347-53. PubMed ID: 24436561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance-guided high-intensity focused ultrasound of uterine fibroids: whole-tumor quantitative perfusion for prediction of immediate ablation response.
    Li C; Jin C; Liang T; Li X; Wang R; Zhang Y; Yang J
    Acta Radiol; 2020 Aug; 61(8):1125-1133. PubMed ID: 31779469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-weighted magnetic resonance imaging using different b-value combinations for the evaluation of treatment results after volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids.
    Ikink ME; Voogt MJ; van den Bosch MA; Nijenhuis RJ; Keserci B; Kim YS; Vincken KL; Bartels LW
    Eur Radiol; 2014 Sep; 24(9):2118-27. PubMed ID: 24962829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective study of ultrasound-guided high intensity focussed ultrasound ablation for multiple uterine fibroids in South Africa.
    He M; Jacobson H; Zhang C; Setzen R; Zhang L
    Int J Hyperthermia; 2018 Dec; 34(8):1304-1310. PubMed ID: 29278943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of T1 perfusion-based classification in magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids.
    Keserci B; Duc NM
    Eur Radiol; 2017 Dec; 27(12):5299-5308. PubMed ID: 28616725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
    Lee JS; Hong GY; Lee KH; Kim TE
    BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.